Proteomics is the large-scale study of proteins on a cellular, tissue, or organismal level. While genomics studies an organism’s genes, proteomics focuses on the proteome, the complete set of proteins produced by an organism.
Syncell is a life science company that has developed a proprietary technology called Microscoop® for high-resolution spatial proteomics.
A uniquely advanced solution to prep for mass spec analysis, the platform’s capabilities and streamlined workflows offers advantages over traditional methods like laser capture microdissection (LCM), antibody-based imaging workflows, and proximity labeling.
Using Syncell’s Microscoop platform with our Synlight-Pure reagent kit allows you to utilize antibody-mediated chemistry and laser-activated precision to enrich proteins from their true biological neighborhood for downstream mass spectrometry.
Microscoop is a technology using photo-biotinylation with ultrahigh-content microscopy. It keeps the tissue intact and labels with light—eliminating the need for cell scraping.
Why cut what you can just label?Optimized for high-throughput proteomics, you can analyze thousands of ROIs per run with no panel limits.
HAWK Biosystems are a biotechnology company situated in the Basque Country. At HAWK, our patented technology, QF-Pro®, enables us to discover and utilise predictive biomarkers in pathology samples from patients. This allows us to predict patient response to treatments and also predict patient survival, particularly in diseases such as cancer. One of our current focuses is the use of QF-Pro® to predict patient response to immunotherapy treatments in skin and lung cancer.
